Bevacizumab Doubles Risk of GI Adverse Events in Key Ovarian Cancer Trial  : Internal Medicine News SGO/Dr Burger/O'Malley Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Thursday, March 10, 2011

Bevacizumab Doubles Risk of GI Adverse Events in Key Ovarian Cancer Trial  : Internal Medicine News SGO/Dr Burger/O'Malley




0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.